LysaKare 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification1 
Decision 
Information 
issued on 
Issued2 / 
affected3  
amended 
on 
N/0014 
Minor change in labelling or package leaflet not 
19/09/2023 
PL 
connected with the SPC (Art. 61.3 Notification) 
IAIN/0013 
A.1 - Administrative change - Change in the name 
13/02/2023 
and/or address of the MAH 
SmPC, 
Labelling and 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
PSUSA/10786
Periodic Safety Update EU Single assessment - l-
09/02/2023 
n/a 
PRAC Recommendation - maintenance 
/202207 
lysine hydrochloride / l-arginine hydrochloride 
PL 
IB/0012 
C.I.11.z - Introduction of, or change(s) to, the 
25/11/2022 
n/a 
obligations and conditions of a marketing 
authorisation, including the RMP - Other variation 
PSUSA/10786
Periodic Safety Update EU Single assessment - l-
01/09/2022 
n/a 
PRAC Recommendation - maintenance 
/202201 
lysine hydrochloride / l-arginine hydrochloride 
N/0010 
Minor change in labelling or package leaflet not 
23/06/2022 
PL 
connected with the SPC (Art. 61.3 Notification) 
PSUSA/10786
Periodic Safety Update EU Single assessment - l-
10/02/2022 
n/a 
PRAC Recommendation - maintenance 
/202107 
lysine hydrochloride / l-arginine hydrochloride 
N/0008 
Minor change in labelling or package leaflet not 
19/10/2021 
PL 
connected with the SPC (Art. 61.3 Notification) 
PSUSA/10786
Periodic Safety Update EU Single assessment - l-
02/09/2021 
n/a 
PRAC Recommendation - maintenance 
/202101 
lysine hydrochloride / l-arginine hydrochloride 
PSUSA/10786
Periodic Safety Update EU Single assessment - l-
11/02/2021 
n/a 
PRAC Recommendation - maintenance 
/202007 
lysine hydrochloride / l-arginine hydrochloride 
PSUSA/10786
Periodic Safety Update EU Single assessment - l-
03/09/2020 
n/a 
PRAC Recommendation - maintenance 
/202001 
lysine hydrochloride / l-arginine hydrochloride 
IB/0003 
B.II.d.2.d - Change in test procedure for the finished 
27/03/2020 
n/a 
product - Other changes to a test procedure 
Page 2/3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(including replacement or addition) 
IA/0002 
B.III.1.a.2 - Submission of a new/updated or 
17/01/2020 
n/a 
deletion of Ph. Eur. Certificate of Suitability to the 
relevant Ph. Eur. Monograph - Updated certificate 
from an already approved manufacturer 
IA/0001 
B.III.1.a.2 - Submission of a new/updated or 
17/12/2019 
n/a 
deletion of Ph. Eur. Certificate of Suitability to the 
relevant Ph. Eur. Monograph - Updated certificate 
from an already approved manufacturer 
Page 3/3 
 
 
 
 
 
 
 
 
 
 
 
 
 
